Roche-AbbVie cancer drug gets accelerated FDA approval

Roche Holding AG said on Wednesday its cancer drug, Venclexta, received accelerated approval from the U.S. Food and Drug Administration as part of a combination treatment for newly diagnosed patients with a form of leukemia.

from Reuters: Health News https://ift.tt/2DAq6Fe
via IFTTT